Monday, Jun 1, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Business | Expert Panel Permits Dr Reddys To Submit Sputnik Light Russian Phase Iii Data In India

Expert panel permits Dr Reddy’s to submit Sputnik Light Russian phase III data in India

On Wednesday, the Subject Expert Committee (SEC) deliberated on the submission for Marketing Authorisation of Sputnik Light in India from Dr Reddy’s

By Telangana Today
Updated On - 1 July 2021, 10:48 PM
Expert panel permits Dr Reddy’s to submit Sputnik Light Russian phase III data in India
Sputnik Light is a single dose Covid-19 vaccine from the makers of Sputnik V.
whatsapp facebook twitter telegram

Hyderabad: Hyderabad-based pharmaceuticals company Dr Reddy’s Laboratories on Thursday said that the single-dose Sputnik Light vaccine can submit Russian safety data for approval in India. Sputnik Light is a single dose Covid-19 vaccine from the makers of Sputnik V and is yet to be approved in the country.

On Wednesday, the Subject Expert Committee (SEC) deliberated on the submission for Marketing Authorisation of Sputnik Light in India from Dr Reddy’s. The company presented to the SEC, interim safety and efficacy data from the phase I / II clinical trial of Sputnik Light in Russia, along with a clinical trial protocol for a phase III trial of Sputnik Light in India.


In view of the fact that Sputnik Light is the first dose component of Sputnik V, and Dr Reddy’s has already generated safety and immunogenicity data on the first dose component in India through its clinical trial and; a phase III efficacy trial is currently underway in Russia on Sputnik Light, the SEC recommended that Dr Reddy’s should submit safety, immunogenicity and efficacy data from the phase III clinical trial of Sputnik Light in Russia to the SEC for its consideration of Marketing Authorisation of Sputnik Light in India.

“Further, the SEC also observed that in view of the safety and immunogenicity data already generated by Dr Reddy’s in India on the first dose component of Sputnik V (in other words, Sputnik Light), there was no need for a separate phase III trial of Sputnik Light in India,” Dr Reddy’s said in a statement.

The company’s clarification comes amid reports of SEC denying permission to Dr Reddy’s for conducting phase 3 trials of Russia’s Covid-19 vaccine Sputnik Light in India.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


 

  • Follow Us :
  • Tags
  • Covid-19
  • COVID-19 vaccine
  • Dr.Reddy's
  • Sputnik Light

Related News

  • Post-Covid steroid use linked to rising hip arthritis among young adults

    Post-Covid steroid use linked to rising hip arthritis among young adults

  • Digital learning reshapes education, offers flexible and personalised learning paths

    Digital learning reshapes education, offers flexible and personalised learning paths

  • Dandari-Gussadi dance troupes in Adilabad await financial aid from government

    Dandari-Gussadi dance troupes in Adilabad await financial aid from government

  • Dr Reddy’s Q2 profit rises 14 per cent to Rs 1,437 crore

    Dr Reddy’s Q2 profit rises 14 per cent to Rs 1,437 crore

Latest News

  • Karnataka celebrates as RCB clinch back-to-back IPL crowns

    4 hours ago
  • India’s curtain raiser events mark Yoga Day build-up in Shanghai

    4 hours ago
  • India-Oman CEPA trade deal takes effect on Monday

    4 hours ago
  • Virat Kohli hails balanced RCB squad after historic IPL triumph

    4 hours ago
  • King Kong Kohli: Virat leads RCB to successive IPL crowns with emphatic win over Titans

    4 hours ago
  • Iran speaker Ghalibaf rules out US deal without securing rights

    4 hours ago
  • West Bengal: Full BJP Cabinet to be sworn in on Monday

    4 hours ago
  • IDF captures strategic Beaufort Castle in Lebanon

    5 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam